Clinical trials
Phase 2 Hepatitis B, Chronic trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
68 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2019 | 4 |
| 2020 | 7 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 12 |
| 2024 | 7 |
| 2025 | 7 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Recruiting | 13 |
| Unknown status | 11 |
| Active, not recruiting | 9 |
| Terminated | 6 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ausper Biopharma Co., Ltd. | 6 |
| Brii Biosciences Limited | 4 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 4 |
| GlaxoSmithKline | 4 |
| The Second Affiliated Hospital of Chongqing Medical University | 4 |
| Chongqing Jiachen Biotechnology Ltd. | 3 |
| Fujian Akeylink Biotechnology Co., Ltd. | 3 |
| Huahui Health | 3 |
| Ascletis Pharmaceuticals Co., Ltd. | 2 |
| Assembly Biosciences | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis B, Chronic | 68 |
| Hepatitis B | 12 |
| Hepatitis | 3 |
| Infections | 2 |
| Blood-Borne Infections | 1 |
| Chronic Disease | 1 |
| Communicable Diseases | 1 |
| DNA Virus Infections | 1 |
| Digestive System Diseases | 1 |
| Disease Attributes | 1 |
Trials
Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.